SCHEMBL2074331

SCHEMBL2074331

COC(=O)c1cc2c([nH]1)CC/C2=C\c1cccc(OC)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.49
NPC1 O15118 3/20 0.49
RAB9A P51151 3/20 0.49
MEN1 O00255 2/20 0.49
KMT2A Q03164 2/20 0.49
PKM P14618 1/20 0.49
ATM Q13315 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
EGFR P00533 1/20 0.46
MAOA P21397 1/20 0.44
MAOB P27338 1/20 0.44
CASP3 P42574 1/20 0.43
SENP8 Q96LD8 1/20 0.43
SENP7 Q9BQF6 1/20 0.43
SENP6 Q9GZR1 1/20 0.43
XDH P47989 2/20 0.43
PIM1 P11309 1/20 0.41
AKR1B1 P15121 1/20 0.41
PIM2 Q9P1W9 1/20 0.41
HSP90AA1 P07900 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2074333 1.00 MAPT (0.49) MAPTNPC1RAB9AMEN1KMT2A
SCHEMBL2074329 1.00 MAPT (0.49) MAPTNPC1RAB9AMEN1KMT2A
SCHEMBL1002792 0.87 MAOA (0.40) MAPTNPC1RAB9AMEN1KMT2A
SCHEMBL1002793 0.87 MAOA (0.40) MAPTNPC1RAB9AMEN1KMT2A
SCHEMBL1002794 0.87 MAOA (0.40) MAPTNPC1RAB9AMEN1KMT2A
SCHEMBL2077300 0.86 IKBKB (0.43) MAPTNPC1RAB9AMEN1KMT2A
SCHEMBL1004246 0.86 HSD11B1 (0.48) MAPTEGFRMAOAMAOBXDH
SCHEMBL1004245 0.86 HSD11B1 (0.48) MAPTEGFRMAOAMAOBXDH
SCHEMBL2077297 0.86 IKBKB (0.43) MAPTNPC1RAB9AMEN1KMT2A
SCHEMBL2077301 0.86 IKBKB (0.43) MAPTNPC1RAB9AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7902252-B2 Inhibitors of D-amino acid oxidase SEPRACOR, INC. (US) 2011-03-08 US disclosed
US-20100029737-A1 INHIBITORS OF D-AMINO ACID OXIDASE SEPRACOR INC. (US) 2010-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100029737-A1 INHIBITORS OF D-AMINO ACID OXIDASE DDO, DAO, ACHE MAPT 444/4885NPC1 4329/4885RAB9A 2295/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.